NCT01169259 2025-11-06VITALBrigham and Women's HospitalPhase 3 Active not recruiting25,871 enrolled 38 charts
NCT00773747 2021-04-30Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)Merck Sharp & Dohme LLCPhase 3 Completed637 enrolled 15 charts